Production of Solid Lipid Nanoparticles-Drug Loadin g and Release Mechanism
Abstract
Solid
lipid nanoparticles (SLNs) introduced at the beginning of the 1990s represents
an alternative carrier system to traditional colloidalcarriers, such as emulsions,
liposomes and polymeric micro and nanoparticles. A number of administration
routes such as topical, oral, parenteral, nasal and pulmonary have been
proposed for the delivery of SLNs. This paper reviews various production
techniques for SLNs including their advantages and disadvantages, drug
incorporation, loading capacity with the factors affecting drug incorporation
and loading capacity and drug release, especially emphasizing on mechanism drug
release
For more info:http://www.jocpr.com/articles/production-of-solid-lipid-nanoparticlesdrug-loading-and-release-mechanism.pdf

Comments
Post a Comment